Advancing the Scientific Understanding of Medical Cannabis Through Real-Time User Data with David Berg, President and CTO of Strainprint

David Berg, President and CTO of Strainprint, explores the current state of the medical cannabis industry in Canada and overseas and how Strainprint is bringing innovation to the industry. He also shares some of the challenges encountered when building and marketing a company in this highly regulated and stigmatized industry, and much more.

Schedule a meeting with Natalie Yeadon: https://www.meetwithnatalie.com

Natalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/

Impetus Digital Website: https://www.impetusdigital.com/

Impetus Digital LinkedIn: https://www.linkedin.com/company/impetus-digital/

Impetus Digital Twitter: https://twitter.com/impetus_digital

Impetus YouTube: https://www.youtube.com/ImpetusDigital

David Berg: https://www.linkedin.com/in/dberg/

Strainprint: https://strainprint.ca/

Impetus Digital has been delivering best-in-class virtual and hybrid meetings, events, and programs for global life science companies since 2008. We work closely with clinical, market access, medical affairs, marketing, medical education, and many other departments to virtualize their internal and external stakeholder meetings, such as advisory boards, learning programs, working groups, and congress engagement initiatives. We partner with clients at all stages of the product life cycle, from R&D to loss of exclusivity.

Click the social media buttons to share this episode with your network!

To learn more about Impetus, our services, and our tools: https://www.meetwithimpetus.com

Natalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/

Impetus Digital Website: Home Page

LinkedIn: https://www.linkedin.com/company/impetus-digital/

Twitter: impetus_digital

YouTube: Impetus Digital